|
1
|
Jain KS, Shah AK, Bariwal J, Shelke SM,
Kale AP, Jagtap JR and Bhosale AV: Recent advances in proton pump
inhibitors and management of acid-peptic disorders. Bioorg Med
Chem. 15:1181–1205. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rew JS: Clinical use of proton pump
inhibitors in gastrointestinal diseases. Korean J Gastroenterol.
47:181–190. 2006.PubMed/NCBI
|
|
3
|
Shin JM, Lee JY, Lee DY, Yoon TY, Lee JC,
Lim EH, Sohn KC, Lee YH, Im M, Seo YJ, et al: Proton pump
inhibitors as a possible cause of vitiligo: An in vivo and in vitro
study. J Eur Acad Dermatol Venereol. 28:1475–1479. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Namazi MR: Proton pump inhibitors may
trigger vitiligo by rendering melanocytes prone to apoptosis. Br J
Dermatol. 158:844–845. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schallreuter KU and Rokos H: From the
bench to the bedside: Proton pump inhibitors can worsen vitiligo.
Br J Dermatol. 156:1371–1373. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Baek SH, Ahn JW, Nam SH, Yoon CS, Shin JC
and Lee SH: S-(−)-10,11-dihydroxyfarnesoic acid methyl ester
inhibits melanin synthesis in murine melanocyte cells. Int J Mol
Sci. 15:12750–12763. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pan T, Li X and Jankovic J: The
association between Parkinson's disease and melanoma. Int J Cancer.
128:2251–2260. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pan T, Zhu J, Hwu WJ and Jankovic J: The
role of alpha-synuclein in melanin synthesis in melanoma and
dopaminergic neuronal cells. PLoS One. 7:e451832012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Parvez S, Kang M, Chung HS and Bae H:
Naturally occurring tyrosinase inhibitors: Mechanism and
applications in skin health, cosmetics and agriculture industries.
Phytother Res. 21:805–816. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim JH, Baek SH, Kim DH, Choi TY, Yoon TJ,
Hwang JS, Kim MR, Kwon HJ and Lee CH: Downregulation of melanin
synthesis by haginin A and its application to in vivo lightening
model. J Invest Dermatol. 128:1227–1235. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Matsui MS, Petris MJ, Niki Y,
Karaman-Jurukovska N, Muizzuddin N, Ichihashi M and Yarosh DB:
Omeprazole, a gastric proton pump inhibitor, inhibits melanogenesis
by blocking ATP7A trafficking. J Invest Dermatol. 135:834–841.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rao F, Yuting Z, Yiran G and Fang C:
Antioxidant and tyrosinase inhibition activities of the
ethanol-insoluble fraction of water extract of Sapium
sebiferum (L.) Roxb. leaves. South Afr J Bot. 93:98–104. 2014.
View Article : Google Scholar
|
|
13
|
Bennett DC, Cooper PJ and Hart IR: A line
of non-tumorigenic mouse melanocytes, syngeneic with the B16
melanoma and requiring a tumour promoter for growth. Int J Cancer.
39:414–418. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Heo JC and Lee SH: Alleviation of
asthma-related symptoms by a derivative of L-allo threonine. Int J
Mol Med. 31:881–887. 2013.PubMed/NCBI
|
|
15
|
Chao HC, Najjaa H, Villareal MO, Ksouri R,
Han J, Neffati M and Isoda H: Arthrophytum scoparium inhibits
melanogenesis through the down-regulation of tyrosinase and
melanogenic gene expressions in B16 melanoma cells. Exp Dermatol.
22:131–136. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Beberok A, Wrześniok D, Otręba M and
Buszman E: Impact of sparfloxacin on melanogenesis and antioxidant
defense system in normal human melanocytes HEMa-LP - An in vitro
study. Pharmacol Rep. 67:38–43. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tuerxuntayi A, Liu YQ, Tulake A, Kabas M,
Eblimit A and Aisa HA: Kaliziri extract upregulates tyrosinase,
TRP-1, TRP-2 and MITF expression in murine B16 melanoma cells. BMC
Complement Altern Med. 14:166–175. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hachiya A, Kobayashi A, Ohuchi A, Takema Y
and Imokawa G: The paracrine role of stem cell factor/c-kit
signaling in the activation of human melanocytes in
ultraviolet-B-induced pigmentation. J Invest Dermatol. 116:578–586.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shin SH and Lee YM: Glyceollins, a novel
class of soybean phytoalexins, inhibit SCF-induced melanogenesis
through attenuation of SCF/c-kit downstream signaling pathways. Exp
Mol Med. 45:e172013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Holla AP, Kumar R, Parsad D and Kanwar A:
Proton pump inhibitor induced depigmentation in vitiligo. J Cutan
Aesthet Surg. 4:46–47. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shin JM and Sachs G: Pharmacology of
proton pump inhibitors. Curr Gastroenterol Rep. 10:528–534. 2008.
View Article : Google Scholar : PubMed/NCBI
|
